Synthesis and Evaluation of Certain Symmetrical Schiff Bases as Inhibitors of MDA-MB-241 Human Breast Cancer Cell Proliferation

Author(s): Smaail Radi, Said Tighadouini, Olivier Feron, Olivier Riant, Yahia N. Mabkhot

Journal Name: Letters in Drug Design & Discovery

Volume 13 , Issue 3 , 2016

Become EABM
Become Reviewer

Graphical Abstract:


A series of symmetrical Schiff base derivatives (L1-L7) were designed by a one-pot condensation reaction of various aldehyde/ketone compounds with hydrazine under mild conditions (room temperature, 3 days), using ether as solvent and acetic acid as catalyst. The target products were characterized and analysed by 1H and 13C NMR, FT-IR and liquid chromatography mass spectrometry (LC/MS). Our research focuses on the identification of synthetically chemotherapeutic substances able to inhibit, delay, or reverse the process of carcinogenesis in several stages. The target compounds presenting two regions for SAR evaluation were screened for their activity toward MDA-MB-241 breast cancer cell proliferation for the first time. Compound (1E, 2E)-1,2-bis(1-(3-nitrophenyl)ethylidene) hydrazine (L6) showed significant inhibitory activity (IC50 = 7.08 µg/mL).

Keywords: Schiff bases, heterocycles, nitro, antitumor activity, breast cancer, cell proliferation.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 12 February, 2016
Page: [205 - 209]
Pages: 5
DOI: 10.2174/1570180812999150812165510
Price: $65

Article Metrics

PDF: 24
PRC: 1